DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Income | ₹2,227 Cr | ₹2,017 Cr | ₹2,087 Cr | ₹1,581 Cr | ₹1,330 Cr |
What is the latest Revenue of DR LAL PATHLABS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,227 Cr |
| Mar2024 | ₹2,017 Cr |
| Mar2023 | ₹2,087 Cr |
| Mar2022 | ₹1,581 Cr |
| Mar2021 | ₹1,330 Cr |
How is Revenue of DR LAL PATHLABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,227 Cr | 10.40 | |
| Mar2024 | ₹2,017 Cr | -3.38 | |
| Mar2023 | ₹2,087 Cr | 32.01 | |
| Mar2022 | ₹1,581 Cr | 18.86 | |
| Mar2021 | ₹1,330 Cr | - | |
Compare Revenue of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,563.7 Cr | -0.2% | -6.4% | -2.4% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹102,289.0 Cr | 2.2% | 0.5% | 3.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹99,868.5 Cr | 7.2% | -2.3% | -3.7% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹64,918.9 Cr | 1% | -6.1% | 33.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,991.0 Cr | -0.4% | -7.5% | 34.8% | Stock Analytics | |
| GLOBAL HEALTH | ₹30,143.5 Cr | 6.3% | -9.4% | 6.3% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -0.2% |
-6.4% |
-2.4% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses